Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: World Neurosurg. 2020 Jan 28;138:e42–e51. doi: 10.1016/j.wneu.2020.01.154

Table 1.

Patient Characteristics and Intraoperative Variables in Patients Undergoing ACDF from ACS-NSQIP 2006 to 2016

2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 P Value
Total ACDF 31 211 538 848 183 373 3853 5725 6577 8578 9937
Demographics
 Age 48.2 [1.5] 51.4 [0.8] 52.5 [0.5] 52.1 [0.4] 52.1 [0.9] 52.7 [0.6] 53.3 [0.2] 53.6 [0.2] 53.3 [0.1] 53.7 [0.1] 54.1 [0.1] <0.001
 BMI 29.4 [1.3] 29.6 [0.4] 29.8 [0.3] 30.0 [0.2] 30.3 [0.5] 30.1 [0.4] 30.3 [0.1] 30.1 [0.1] 30.3 [0.1] 30.4 [0.1] 30.5 [0.1] 0.003
 Male 14 (45.2%) 88 (41.7%) 250 (46.5%) 417 (49.2%) 90 (49.2%) 195 (57.4%) 1850 (48.4%) 2717 (47.7%) 3289 (50.3%) 4251 (49.9%) 2768 (50.4%) 0.001
Race <0.001
 White NA 0 395 (73.4%) 679 (80.1%) 135 (73.8%) 268 (10.5%) 3195 (82.9%) 4604 (82.2%) 5338 (81.2%) 6887 (80.3%) 7947 (80.0%)
 Black NA 1 (0.5%) 54 (10.0%) 67 (7.9%) 28 (15.3%) 56 (15.0%) 357 (9.3%) 493 (8.6%) 615 (9.4%) 878 (10.2%) 991 (10.0%)
 Asian NA 0 7 (1.3%) 5 (0.6%) 2 (1.1%) 9 (2.4%) 61 (1.6%) 117 (2.0%) 128 (1.9%) 172 (2.0%) 174 (1.8%)
 American Indian/Alaska Native NA 0 16 (3.0%) 21 (2.5%) 0 0 7 (0.2%) 35 (0.6%) 64 (1.0%) 82 (1.0%) 59 (0.6%)
 Native Hawaiian/Pacific Islander NA 0 0 0 0 1 (0.3%) 13 (0.3%) 18 (0.3%) 35 (0.5%) 29 (0.3%) 38 (0.4%)
Ethnicity <0.001
 Hispanic NA 0 32 (5.9%) 35 (4.1%) 9 (4.9%) 21 (5.6%) 170 (4.4%) 239 (4.2%) 316 (4.8%) 417 (4.9%) 465 (4.7%)
 Non-Hispanic NA 1 (0.5%) 506 (94.1%) 813 (95.9%) 166 (90.7%) 325 (87.1%) 3507 (91.0%) 5183 (90.5%) 5758 (87.5%) 7542 (87.9%) 8583 (86.4%)
Comorbidities
 Diabetes (with insulin) 1 (3.2%) 8 (3.8%) 15 (2.8%) 35 (4.1%) 14 (7.7%) 27 (7.2%) 161 (4.2%) 269 (4.7%) 354 (5.4%) 439 (5.1%) 539 (5.7%) <0.001
 Current smoker (within 1 year) 18 (58.1%) 82 (38.9%) 183 (34.0%) 280 (33.0%) 53 (29.0%) 114 (30.6%) 1157 (30.0%) 1692 (29.6%) 1831 (27.8%) 2261 (26.4%) 2633 (26.5%) <0.001
Dyspnea <0.001
 Dyspnea with moderate exertion 8 (25.8%) 11 (5.2%) 33 (6.1%) 38 (4.5%) 17 (9.3%) 15 (4.0%) 235 (6.1%) 302 (5.3%) 289 (4.4%) 379 (4.4%) 421 (4.2%)
 Dyspnea at rest 0 0 3 (0.6%) 1 (0.1%) 0 20 (0.5%) 20 (0.5%) 9 (0.2%) 10 (0.2%) 14 (0.2%) 34 (0.3%)
Functional status 0.054
 Partially dependent 0 10 (4.7%) 10 (1.9%) 21 (2.5%) 5 (2.7%) 10 (2.7%) 58 (1.5%) 63 (1.1%) 72 (1.1%) 93 (1.1%) 129 (1.3%)
 Totally dependent 0 2 (0.9%) 2 (0.4%) 1 (0.1%) 1 (0.5%) 0 (0.0%) 8 (0.2%) 2 (0.0%) 6 (0.1%) 6 (0.1%) 9 (0.1%)
 COPD 2 (6.5%) 4 (1.9%) 16 (3.0%) 24 (2.8%) 6 (3.3%) 10 (2.9%) 129 (3.4%) 253 (4.4%) 282 (4.3%) 337 (3.9%) 410 (4.1%) 0.052
 Hypertension requiring medication 12 (38.7%) 84 (39.8%) 226 (42.0%) 358 (42.2%) 78 (42.6%) 157 (42.10%) 1648 (42.8%) 2453 (42.8%) 2847 (43.3%) 3784 (44.1%) 4439 (44.7%) 0.332
 On dialysis 0 0 0 0 1 (0.5%) 3 (0.8%) 16 (0.4%) 8 (0.1%) 13 (0.2%) 10 (0.1%) 20 (0.2%) 0.005
 Open wound or wound infection 0 0 1 (0.2%) 1 (0.1%) 3 (1.6%) 1 (0.3%) 17 (0.4%) 11 (0.2%) 9 (0.1%) 21 (0.2%) 18 (0.2%) 0.055
 Steroid use 1 (3.2%) 9 (4.3%) 11 (2.0%) 26 (3.1%) 4 (2.2%) 20 (5.4%) 119 (3.1%) 166 (2.9%) 183 (2.8%) 274 (3.2%) 274 (3.2%) 0.055
 >10% weight loss in <6 months 0 2 (0.9%) 1 (0.2%) 7 (0.8%) 1 (0.5%) 1 (0.3%) 4 (0.1%) 10 (0.2%) 10 (0.2%) 10 (0.1%) 12 (0.1%) 0.818
 Bleeding disorders 0 3 (1.4%) 4 (0.7%) 10 (1.2%) 0 5 (1.3%) 29 (0.8%) 51 (0.9%) 64 (1.0%) 84 (1.0%) 111 (1.1%) 0.614
Sepsis 0.766
 SIRS 1 (3.2%) 1 (0.5%) 4 (0.7%) 3 (0.4%) 1 (0.5%) 2 (0.5%) 6 (0.2%) 8 (0.1%) 11 (0.2%) 15 (0.2%) 20 (0.2%)
 Sepsis 0 0 0 1 (0.1%) 0 0 0 0 0 0 0
 Preoperative transfusion RBC 0 0 0 0 1 (0.0%) 0 (0.0%) 1 (0.0%) 0 (0.0%) 1 (0.0%) 2 (0.0%) 0 (0.0%) 0.943
Inpatient vs. outpatient <0.001
 Inpatient 22 (71.0%) 175 (82.9%) 460 (85.5%) 719 (84.8%) 154 (84.2%) 323 (86.6%) 2974 (77.2%) 4347 (75.9%) 4916 (74.7%) 6187 (72.1%) 7012 (70.6%)
 Outpatient 9 (29.0%) 36 (17.1%) 78 (14.5%) 129 (15.2%) 29 (15.8%) 50 (13.4%) 879 (22.8%) 1378 (24.1%) 1661 (25.3%) 2391 (27.9%) 2925 (29.4%)
 Radiculopathy 0 0 0 0 0 0 0 0 5 837 3543 <0.001
 Myelopathy 5 (16.1%) 75 (35.5%) 172 (32.0%) 274 (32.3%) 174 (95.1%) 350 (93.8%) 1111 (28.8%) 1754 (30.6%) 2055 (31.2%) 2454 (28.6%) 2184 (22.0%) <0.001
ASA class <0.001
 I: no disturbance 0 20 (9.5%) 24 (4.5%) 46 (5.4%) 13 (7.1%) 15 (4.0%) 177 (4.6%) 241 (4.2%) 294 (4.5%) 368 (4.3%) 402 (4.0%)
 II: mild disturbance 21 (67.7%) 123 (58.3%) 327 (60.8%) 498 (58.7%) 93 (50.8%) 214 (57.4%) 2240 (58.1%) 3339 (58.3%) 3760 (57.2%) 4846 (56.5%) 5308 (53.4%)
 III: severe disturbance 10 (32.3%) 59 (28.0%) 175 (32.5%) 292 (34.4%) 75 (41.0%) 139 (37.3%) 1366 (35.5%) 2058 (35.9%) 2427 (36.9%) 3231 (37.7%) 4060 (40.9%)
 IV: life threatening 0 8 (3.8%) 11 (2.0%) 11 (1.3%) 2 (1.1%) 5 (1.3%) 63 (1.6%) 75 (1.3%) 90 (1.4%) 125 (1.5%) 154 (1.5%)
 Operation time 143.3 [11.4] 150.8 [4.7] 137.5 [3.0] 130.5 [2.2] 133.2 [4.4] 130.8 [3.4] 124.3 [1.1] 122.1 [0.9] 124.3 [0.8] 124.0 [0.7] 124.5 [0.7] 0.003
Hospital variables
 Total hospital length of stay 1.7 [0.3] 2.1 [0.3] 1.9 [0.1] 2.0 [0.1] 1.9 [0.6] 6.1 [2.0] 1.6 [0.1] 1.4 [0.0] 1.6 [0.0] 1.5 [0.0] 1.5 [0.0] <0.001
 Days from operation to discharge 1.6 [0.2] 1.9 [0.2] 1.7 [0.1] 1.8 [0.1] 1.5 [0.6] 2.1 [0.2] 1.6 [0.1] 1.5 [0.0] 1.5 [0.0] 1.5 [0.0] 1.5 [0.0] <0.001

Data are displayed as n (%) or mean [standard deviation].

ACDF, anterior cervical discectomy and fusion; ACS-NSQIP, American College of Surgeons National Surgical Quality Improvement Program database; BMI, body mass index; NA, not available; COPD, chronic obstructive pulmonary disease; SIRS, systemic inflammatory response syndrome; RBC, red blood cell; ASA, American Society of Anesthesiologists.